AIO offers new technology to optimize cataract surgery outcomes
AIO is proud to announce yet another FDA approved technology aimed at improving visual outcomes with cataract surgery. The newest addition to our cataract surgery technology is called ORA™ (Optiwave Refractive Analysis) System. It is currently the most advanced intraoperative diagnostic tool for cataract surgery available with over 200,000 procedures performed and 500 units placed to date globally.
The ORA™ System, Now Featuring VerifEye+™ provides precise, real-time measurements during surgery that are not possible with conventional measurements and instruments. It works by directing an invisible beam of low intensity light into the eye during cataract surgery. This light then reflects back from the eye and sensors within the ORA device analyze the eye’s unique optical characteristics. This information is utilized by our surgeons to select the most accurate intraocular lens implant and more accurately place intraocular lenses improve the visual outcomes after surgery.
“We continuously seek new ways to address the needs of our cataract patients, particularly those who live with astigmatism and presbyopia,” said Dr. Cibik. “The ORA System provides intraoperative measurements and is designed to help improve patient outcomes through optimal IOL selection and placement during surgery.”